Inovalon Holdings, Inc. (INOV) Shares Sold by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. cut its stake in Inovalon Holdings, Inc. (NASDAQ:INOV) by 53.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,300 shares of the technology company’s stock after selling 12,749 shares during the quarter. UBS Asset Management Americas Inc.’s holdings in Inovalon Holdings were worth $149,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Inovalon Holdings by 3.8% in the first quarter. Vanguard Group Inc. now owns 4,809,281 shares of the technology company’s stock valued at $60,598,000 after purchasing an additional 174,304 shares during the period. FMR LLC raised its position in shares of Inovalon Holdings by 6.7% in the first quarter. FMR LLC now owns 2,565,829 shares of the technology company’s stock valued at $32,329,000 after purchasing an additional 161,500 shares during the period. Geode Capital Management LLC raised its position in shares of Inovalon Holdings by 4.0% in the first quarter. Geode Capital Management LLC now owns 500,364 shares of the technology company’s stock valued at $6,304,000 after purchasing an additional 19,367 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Inovalon Holdings by 86.7% in the first quarter. Goldman Sachs Group Inc. now owns 472,597 shares of the technology company’s stock valued at $5,954,000 after purchasing an additional 219,465 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in shares of Inovalon Holdings by 9.9% in the second quarter. Bank of New York Mellon Corp now owns 344,848 shares of the technology company’s stock valued at $4,535,000 after acquiring an additional 30,922 shares in the last quarter. 28.68% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/11/08/inovalon-holdings-inc-inov-shares-sold-by-ubs-asset-management-americas-inc.html.
In other news, CEO Keith R. Dunleavy acquired 62,000 shares of Inovalon Holdings stock in a transaction on Wednesday, September 13th. The shares were purchased at an average cost of $16.38 per share, for a total transaction of $1,015,560.00. Following the completion of the purchase, the chief executive officer now directly owns 270,000 shares of the company’s stock, valued at approximately $4,422,600. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 48.28% of the company’s stock.
Several equities analysts recently commented on INOV shares. BidaskClub downgraded shares of Inovalon Holdings from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Morgan Stanley upgraded shares of Inovalon Holdings from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $9.00 to $14.00 in a research note on Tuesday, September 12th. TheStreet upgraded shares of Inovalon Holdings from a “d+” rating to a “c-” rating in a research note on Thursday, October 5th. ValuEngine upgraded shares of Inovalon Holdings from a “sell” rating to a “hold” rating in a research note on Wednesday, September 6th. Finally, KeyCorp restated a “hold” rating on shares of Inovalon Holdings in a research note on Tuesday, September 12th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $14.00.
Inovalon Holdings, Inc. (NASDAQ:INOV) opened at $15.15 on Wednesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 5.62 and a quick ratio of 5.62. Inovalon Holdings, Inc. has a one year low of $8.60 and a one year high of $17.80. The company has a market cap of $2,223.62, a PE ratio of 72.62, a P/E/G ratio of 4.46 and a beta of 1.29.
Inovalon Holdings (NASDAQ:INOV) last announced its quarterly earnings data on Wednesday, November 1st. The technology company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.01. The firm had revenue of $115.90 million for the quarter, compared to the consensus estimate of $114.79 million. Inovalon Holdings had a net margin of 4.07% and a return on equity of 4.63%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.10 earnings per share. research analysts anticipate that Inovalon Holdings, Inc. will post 0.24 EPS for the current fiscal year.
Inovalon Holdings Profile
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Stock Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related stocks with our FREE daily email newsletter.